By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

Proposed Indian bills could oust elected officials jailed over 30 days, sparking opposition uproar. Critics fear misuse ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

Japanese pharmaceutical giant Takeda is considering conducting global clinical trials in India as part of a broader strategy ...

Over the past 10 years, from 2015 to 2025, Nepalis have endured relentless natural disasters, economic crises, health emergencies, and systemic issues that have profoundly impacted their lives.

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...